Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease
Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors.